Four biotech stocks surging on optimism about drug trials, product launches
March 02, 2017 at 14:52 PM EST
Harry Boxer highlights bluebird bio, Amicus Therapeutics, Kite Pharma and NeuroDerm.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.